![Diana M. Hablitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Diana Hablitz joined TransMolecular in December 2000 as Director, Preclinical and Clinical Development.
Ms. Hablitz has more than 20 years of nursing, clinical trials management, and research experience, including more than seven years of neurological clinical trials at Baylor College of Medicine and the University of Alabama at Birmingham.
From 1998 to 1999, she was the Research Nurse Manager for the Department of Emergency at the University of Alabama at Birmingham, and from 1999 to 2000, she was Clinical Trials Coordinator for Axcan Scandipharm Inc.
Ms. Hablitz earned her B.S.N.
and M.S.N.
from the University of Alabama at Birmingham and has been a certified nurse practitioner since 19
Anciens postes connus de Diana M. Hablitz
| Sociétés | Poste | Fin |
|---|---|---|
TransMolecular, Inc.
 TransMolecular, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes novel & proprietary products | Directeur Technique/Scientifique/R&D | 27/06/2011 |
Formation de Diana M. Hablitz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
The University of Alabama
 The University of Alabama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransMolecular, Inc.
TransMolecular, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes novel & proprietary products | Health Technology |
